Aton Biotech - A Henlius Company is the fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform. Our service ranges from cell line development to clinical and end-to-end CDMO commercial manufacturing services, including development of mammalian expressed monoclonal antibodies, fusion proteins, bispecific antibodies, ADC, etc.

Aton Biotech has two R&D &manufacturing sites in Shanghai. Both are equipped with the latest technology and fully compliant with the cGMP requirement of the NMPA, EMA and FDA.

Trust an experienced CDMO partner of choice with:

30+ Molecules (mAb, BsAb, fusion protein, ADC, etc.)

50+ IND Approvals (USA, China, etc.)

100% Tech Transfer success Rate

100+ Tox and Clinical Batch Production

450+ Commercial Batch Production

Learn more by visiting us:  https://atonbio.com/en/Index.html 

Contact us: https://bit.ly/3U9xj3i 

Thank you.

Min Park

Chief Business Officer

Aton Biotech - A Henlius Company